35
Participants
Start Date
October 31, 2006
Primary Completion Date
April 30, 2009
Study Completion Date
May 31, 2009
Enoxaparin
Lovenox 40mg SC daily (30mg SC daily if creatinine clearance \< 30) for 21 days
University of Alberta Hospital, Edmonton
Grey Nuns Hospital, Edmonton
Collaborators (1)
Edmonton Civic Employees Research Fund
OTHER
Sanofi
INDUSTRY
University of Alberta
OTHER